1 404

Cited 24 times in

Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report.

DC Field Value Language
dc.contributor.author김진석-
dc.date.accessioned2015-04-23T17:15:13Z-
dc.date.available2015-04-23T17:15:13Z-
dc.date.issued2010-
dc.identifier.issn0145-2126-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/102112-
dc.description.abstractFourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.-
dc.description.statementOfResponsibilityopen-
dc.format.extent1175~1179-
dc.relation.isPartOfLEUKEMIA RESEARCH-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdolescent-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHAntineoplastic Combined Chemotherapy Protocols/therapeutic use-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHLymphoma, Non-Hodgkin/drug therapy-
dc.subject.MESHLymphoma, Non-Hodgkin/pathology*-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOvarian Neoplasms/pathology-
dc.subject.MESHOvarian Neoplasms/secondary*-
dc.subject.MESHPrognosis-
dc.subject.MESHRecurrence-
dc.subject.MESHSurvival Rate-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHYoung Adult-
dc.titleClinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorJina Yun-
dc.contributor.googleauthorSeok Jin Kim-
dc.contributor.googleauthorJong Ho Won-
dc.contributor.googleauthorChul Won Choi-
dc.contributor.googleauthorHyeon Seok Eom-
dc.contributor.googleauthorJin Seok Kim-
dc.contributor.googleauthorMin Kyoung Kim-
dc.contributor.googleauthorJae-Yong Kwak-
dc.contributor.googleauthorWon Seog Kim-
dc.contributor.googleauthorCheolwon Suh-
dc.identifier.doi10.1016/j.leukres.2010.02.010-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01017-
dc.relation.journalcodeJ02166-
dc.identifier.eissn1873-5835-
dc.identifier.pmid20206997-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0145212610000901-
dc.contributor.alternativeNameKim, Jin Seok-
dc.contributor.affiliatedAuthorKim, Jin Seok-
dc.citation.volume34-
dc.citation.number9-
dc.citation.startPage1175-
dc.citation.endPage1179-
dc.identifier.bibliographicCitationLEUKEMIA RESEARCH, Vol.34(9) : 1175-1179, 2010-
dc.identifier.rimsid49553-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.